Poorly differentiated thyroid carcinoma: An institutional experience

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• Poorly differentiated thyroid carcinoma (PDTC) is an uncommon thyroid malignancy.
• Standardized treatment guidelines for PDTC are currently lacking.
• Understanding PDTC's clinicopathological features is crucial for improving patient outcomes.

Purpose of the Study:

• To analyze the clinicopathological features of patients diagnosed with poorly differentiated thyroid carcinoma (PDTC).
• To review data from PDTC patients to identify key characteristics and potential trends.
• To provide insights that may contribute to the development of future treatment strategies for PDTC.

Main Methods:

• Retrospective analysis of data from 21 PDTC patients treated at the institution.
• Collection and review of patient data including demographics, symptoms, cytology, pathology, and surgical outcomes.
• Descriptive analysis of patient characteristics based on presentation, treatment, metastasis, age, and concurrent conditions.

Main Results:

• Analysis included 21 operated PDTC cases, examining age, sex, symptoms, metastasis, and pathological findings.
• Descriptive analyses were performed for patients with distant metastasis, juvenile cancer, and hyperthyroidism.
• Variations in initial surgical plans for different patient presentations were documented.

Conclusions:

• The study presents a detailed analysis of 21 poorly differentiated thyroid carcinoma (PDTC) cases.
• The findings clarify the clinicopathological features of PDTC patients.
• This research offers valuable insights for future studies on PDTC treatment, despite study limitations.